Announcing Brand New Agenda for 2nd Annual Biotech and Money London

What do the Global BD heads of GSK, AstraZeneca, rockstar investors like Sir Chris Evans, the finest collection of VCs and CVCs, generalist investors and fund managers and the UK’s leading life science CEOs have in common?

They are all getting together at the 2nd annual Biotech and Money London event, taking place on 2-3 February 2016 in London, to brainstorm ideas to further the funding, financing, business development and partnering opportunities of UK innovation.

Want to know what’s in it for you? Visit here to see the brochure.

Biotech, Diagnostic, Medtech and Device companies seeking funding, financing or partnering opportunities will find no better place to access opportunities and ideas to move your business forward.

Packed with bold, fresh ideas and formats, investor and life science participants that pack a punch, innovation from the UK’s finest emerging and established life science companies and incredible opportunities for networking and deal making.



Some things to look out for:

  • Launch of our bold new Report on Healthcare Investment in the UK - commissioned by over 25 UK CEO’s, and backed by EY, Neil Woodford, the BIA, Imperial Innovations and a host of other companies
  • Brand new Pharma focus - with top BD heads Luigi de la Corte and Shaun Grady of GSK and Astrazeneca as part of a Pharma forum focus day
  • Even more powerful discussion groups with enhanced peer-2-peer idea exchanges
  • Our exclusive HealthEx CEO forum for publicly listed life science CEO’s and CFO’s
  • Exclusive presentations from the ‘UK’s One’s to Watch’ - showcasing the finest innovative life science companies coming out of the UK
  • The ability for companies like your’s to upload an investor / partnering slide deck to our private portal, to be viewed by attending Investors and Pharma




Tags :

Leave a comment